Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients

Bárbara Balandín; Vicente Pintado; María José Pérez-Pedrero; Fernando Martínez-Sagasti; Milagros Sancho-González; Cruz Soriano-Cuesta; Cristina Martín-Dal Gesso; Marta Chicot; Rafael Ruiz de Luna; María José Asensio-Martín; Mercedes Catalan; Juan José Díaz-Díaz; Nieves Carbonell; Reyes Iranzo; Ana Royuela; Daniel Ballesteros

doi:10.1016/j.ijantimicag.2024.107121

Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients

Int J Antimicrob Agents. 2024 May;63(5):107121. doi: 10.1016/j.ijantimicag.2024.107121. Epub 2024 Feb 24.

Authors

Bárbara Balandín¹, Vicente Pintado², María José Pérez-Pedrero³, Fernando Martínez-Sagasti⁴, Milagros Sancho-González⁵, Cruz Soriano-Cuesta⁶, Cristina Martín-Dal Gesso⁷, Marta Chicot⁸, Rafael Ruiz de Luna⁹, María José Asensio-Martín¹⁰, Mercedes Catalan¹¹, Juan José Díaz-Díaz¹², Nieves Carbonell¹³, Reyes Iranzo¹⁴, Ana Royuela¹⁵, Daniel Ballesteros¹⁶

Affiliations

¹ Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Electronic address: balandinmoreno@gmail.com.
² Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain.
³ Department of Critical Care Medicine, Hospital Universitario de Toledo, Toledo, Spain.
⁴ Department of Critical Care Medicine, Hospital Universitario Clínico San Carlos, Madrid, Spain.
⁵ Department of Critical Care Medicine, Hospital Universitario Gregorio Marañón, Madrid, Spain.
⁶ Department of Critical Care Medicine, Hospital Universitario Ramón y Cajal, Madrid, Spain.
⁷ Department of Critical Care Medicine, Hospital Universitario del Sudeste, Madrid, Spain.
⁸ Department of Critical Care Medicine, Hospital Universitario de La Princesa, Madrid, Spain.
⁹ Department of Critical Care Medicine, Hospital Universitario Fundación de Alcorcón, Madrid, Spain.
¹⁰ Department of Critical Care Medicine, Hospital Universitario La Paz, Madrid, Spain.
¹¹ Department of Critical Care Medicine, Hospital Universitario Doce de Octubre, Madrid, Spain.
¹² Department of Critical Care Medicine, Hospital Universitario de Gran Canaria Doctor Negrín; Gran Canaria, Spain.
¹³ Department of Critical Care Medicine, Hospital Clínico Universitario de Valencia.
¹⁴ Department of Anesthesiology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
¹⁵ Clinical Biostatistics, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain.
¹⁶ Department of Critical Care Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

PMID: 38408494
DOI: 10.1016/j.ijantimicag.2024.107121

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Aged
Anti-Bacterial Agents* / therapeutic use
Cefiderocol*
Cephalosporins* / therapeutic use
Critical Illness*
Female
Gram-Negative Bacteria / drug effects
Gram-Negative Bacterial Infections* / drug therapy
Gram-Negative Bacterial Infections* / microbiology
Humans
Male
Middle Aged
Treatment Outcome

Substances

Anti-Bacterial Agents
Cefiderocol
Cephalosporins